AU2821695A - Endothelial-monocyte activating polypeptide iii - Google Patents

Endothelial-monocyte activating polypeptide iii

Info

Publication number
AU2821695A
AU2821695A AU28216/95A AU2821695A AU2821695A AU 2821695 A AU2821695 A AU 2821695A AU 28216/95 A AU28216/95 A AU 28216/95A AU 2821695 A AU2821695 A AU 2821695A AU 2821695 A AU2821695 A AU 2821695A
Authority
AU
Australia
Prior art keywords
endothelial
activating polypeptide
polypeptide iii
monocyte activating
monocyte
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28216/95A
Other languages
English (en)
Inventor
Timothy A Coleman
Henrik S. Olsen
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of AU2821695A publication Critical patent/AU2821695A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU28216/95A 1995-06-07 1995-06-07 Endothelial-monocyte activating polypeptide iii Abandoned AU2821695A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1995/007328 WO1996040719A1 (fr) 1995-06-07 1995-06-07 Polypeptide de type iii activateur des monocytes et des cellules endotheliales

Publications (1)

Publication Number Publication Date
AU2821695A true AU2821695A (en) 1996-12-30

Family

ID=22249285

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28216/95A Abandoned AU2821695A (en) 1995-06-07 1995-06-07 Endothelial-monocyte activating polypeptide iii

Country Status (5)

Country Link
EP (1) EP0873349A4 (fr)
JP (1) JP3759168B2 (fr)
AU (1) AU2821695A (fr)
CA (1) CA2221821A1 (fr)
WO (1) WO1996040719A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885798A (en) * 1996-08-28 1999-03-23 Incyte Pharmaceuticals, Inc. DNA encoding a monocyte activating cytokine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5641867A (en) * 1993-09-29 1997-06-24 The Trustees Of Columbia University In The City Of New York Antibody which specifically binds to endothelial-monocyte activating polypeptide II

Also Published As

Publication number Publication date
EP0873349A1 (fr) 1998-10-28
WO1996040719A1 (fr) 1996-12-19
EP0873349A4 (fr) 2001-03-14
JPH11507506A (ja) 1999-07-06
CA2221821A1 (fr) 1996-12-19
JP3759168B2 (ja) 2006-03-22

Similar Documents

Publication Publication Date Title
AU7203496A (en) Novel peptides
AU5235796A (en) o-hydroxyphenyl-s-triazines
AU4780896A (en) Core-board
AU6000496A (en) Phenylpyridazinones
AU5896396A (en) Pyridine-microbicides
AU1030997A (en) Taphane
AU4996696A (en) 2-benzyl-3-arylbenzothiophenes
AU5147496A (en) Fucopeptides
AU4427296A (en) Novel peptide
AU4394396A (en) Modified peptides
AU2131195A (en) Prophenins - antibiotic peptides
AU5593896A (en) Benzisothiazolyl-substituted aminomethylchromans
AU5500196A (en) Anti-transpirants
AU4382896A (en) Acetylimidazobenzodiazepines
AU7520396A (en) Abl-interactor protein
AU5108596A (en) Morphine-3-esters
AU5284296A (en) Immune-evading proteins
AU6215196A (en) Piperidinylmethyloxazolidinones
AU5917896A (en) Poly-beta-1-4-N-acetylglucosamine
AU5013796A (en) Wireclamp
AUPM489194A0 (en) Peptides
AU5107096A (en) Haemodialyser
AU5161296A (en) Anti-haemorrhagic peptides
AU6153396A (en) E6ap-binding proteins
AU4569496A (en) Tetralinyl- and indanyl-ethylamides